April 30, 2017
Recommended Topic Related To:


"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...



Acthrel Patient Information including How Should I Take

What should I discuss with my health care provider before receiving corticorelin ovine trifluate (Acthrel)?

Tell your doctor about any allergies or medical conditions you have.

FDA pregnancy category C. This medication may be harmful to an unborn baby. Before you receive corticorelin ovine trifluate, tell your doctor if you are pregnant.

It is not known whether corticorelin ovine trifluate passes into breast milk or if it could harm a nursing baby. Do not receive this medication without telling your doctor if you are breast-feeding a baby.

How is corticorelin ovine trifluate given (Acthrel)?

You will receive corticorelin ovine trifluate in a clinic or hospital setting. The medication is given as a single injection through a needle placed into a vein. Your blood will be tested before and after you receive the injection.

During the corticorelin test, your caregivers will need to draw at least 5 blood samples from you. This will help your doctor determine more about your condition.

In most cases, the blood is tested 15 minutes before and then right before you receive the injection. These tests will give your doctor two "baseline" measurements.

After you receive corticorelin ovine trifluate, your blood will be drawn again at 15 minutes, 30 minutes, and 60 minutes after the injection. This will help your doctor determine more about your condition.

Side Effects Centers

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.